Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan

Experimental Hematology

Volumn 40, Issue 6, 2012, Pages 466-476

  Mazzoni, Elisa ^a   Rigolin, Gian Matteo ^a   Alaribe, Franca Nneka ^a   Pancaldi, Cecilia ^a   Maniero, Stefania ^a   Comar, Manola ^b   Martini, Fernanda ^a   Tognon, Mauro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; KARYOTYPE; LIFESPAN; MORPHOLOGY; PRIORITY JOURNAL; PROGENY; PURIFICATION; SIMIAN VIRUS 40; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS LOAD;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TRANSFORMED; CELL SURVIVAL; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; SIMIAN VIRUS 40; T-LYMPHOCYTES;

MIRIDAE; SIMIAN VIRUS 40;

EID: 84860838000     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.02.008     Document Type: Article

References (69)

1. Barbanti-Brodano G., Martini F., De Mattei M., Lazzarin L., Corallini A., Tognon M. BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res 1998, 50:69-99.
2. Martini F., Corallini A., Balatti V., Sabbioni S., Pancaldi C., Tognon M. Simian virus 40 in humans. Infect Agent Cancer 2007, 2:13.
3. Barbanti-Brodano G., Sabbioni S., Martini F., Negrini M., Corallini A., Tognon M. Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 2004, 318:1-9.
4. Barbanti-Brodano G., Sabbioni S., Martini F., Negrini M., Corallini A., Tognon M. BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 2006, 577:319-341.
5. Ali S.H., DeCaprio J.A. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 2001, 11:15-23.
6. Ahuja D., Saenz-Robles M.T., Pipas J.M. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 2005, 24:7729-7745.
7. Pipas J.M. SV40: cell transformation and tumorigenesis. Virology 2009, 384:294-303.
8. Crosby L.M., Moore T.M., George M., et al. Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and large T antigen-induced transcripts. Cancer Cell Int 2010, 10:4.
9. Pipas J.M., Levine A.J. Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 2001, 11:23-30.
10. Garcea R.L., Imperiale M.J. Simian virus 40 infection of humans. J Virol 2003, 77:5039-5045.
11. Imperiale M.J. Oncogenic transformation by the human polyomaviruses. Oncogene 2001, 20:7917-7923.
12. Saenz-Robles M.T., Sullivan C.S., Pipas J.M. Transforming functions of simian virus 40. Oncogene 2001, 20:7899-7907.
13. Dyson N., Bernards R., Friend S.H., et al. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 1990, 64:1353-1356.
14. Levine A.J. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Virology 2009, 384:285-293.
15. Theile M., Strauss M., Luebbe L., Scherneck S., Krause H., Geissler E. SV40-induced somatic mutations: possible relevance to viral transformation. Cold Spring Harb Symp Quant Biol 1980, (44 Pt 1):377-382.
16. Stewart N., Bacchetti S. Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 1991, 180:49-57.
17. Ray F.A., Peabody D.S., Cooper J.L., Cram L.S., Kraemer P.M. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 1990, 42:13-31.
18. Woods C., LeFeuvre C., Stewart N., Bacchetti S. Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53. Oncogene 1994, 9:2943-2950.
19. Coe J.E., Green I. B-cell origin of hamster lymphoid tumors induced by simian virus 40. J Natl Cancer Inst 1975, 54:269-270.
20. Diamandopoulos G.T. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972, 176:173-175.
21. Van Dyke T.A., Finlay C., Miller D., Marks J., Lozano G., Levine A.J. Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J Virol 1987, 61:2029-2032.
22. McNees A.L., Vilchez R.A., Heard T.C., et al. SV40 lymphomagenesis in Syrian golden hamsters. Virology 2009, 384:114-124.
23. ter Brugge P.J., Ta V.B., de Bruijn M.J., et al. A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen. Blood 2009, 114:119-127.
24. Dolcetti R., Martini F., Quaia M., et al. Simian virus 40 sequences in human lymphoblastoid B-cell lines. J Virol 2003, 77:1595-1597.
25. Martini F., Iaccheri L., Lazzarin L., et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996, 56:4820-4825.
26. Martini F., Dolcetti R., Gloghini A., et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998, 78:669-674.
27. Pancaldi C., Balatti V., Guaschino R., et al. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect 2009, 58:53-60.
28. Comar M., Zanotta N., Bovenzi M., Campello C. JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy. J Med Virol 2010, 82:1236-1240.
29. Vanchiere J.A., White Z.S., Butel J.S. Detection of BK virus and simian virus 40 in the urine of healthy children. J Med Virol 2005, 75:447-454.
30. Li R.M., Mannon R.B., Kleiner D., et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002, 74:1497-1504.
31. Li R.M., Branton M.H., Tanawattanacharoen S., Falk R.A., Jennette J.C., Kopp J.B. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002, 13:2320-2330.
32. Jafar S., Rodriguez-Barradas M., Graham D.Y., Butel J.S. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 1998, 54:276-284.
33. Vanchiere J.A., Abudayyeh S., Copeland C.M., Lu L.B., Graham D.Y., Butel J.S. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol 2009, 47:2388-2391.
34. Butel J.S., Arrington A.S., Wong C., Lednicky J.A., Finegold M.J. Molecular evidence of simian virus 40 infections in children. J Infect Dis 1999, 180:884-887.
35. Butel J.S., Jafar S., Wong C., et al. Evidence of SV40 infections in hospitalized children. Hum Pathol 1999, 30:1496-1502.
36. Patel N.C., Vilchez R.A., Killen D.E., et al. Detection of polyomavirus SV40 in tonsils from immunocompetent children. J Clin Virol 2008, 43:66-72.
37. Shaikh S., Skoczylas C., Longnecker R., Rundell K. Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines. J Virol 2004, 78:4917-4920.
38. Stratton K.A.D., McCormik M.C. SV40 contamination of polio vaccine and cancer. Institute of Medicine of the National Academies 2002, The National Academic Press, Washington, DC.
39. Du M.Q., Diss T.C., Liu H., et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 2002, 100:3415-3418.
40. Fwu C.W., Chien Y.C., You S.L., et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology 2011, 53:1217-1225.
41. Castillo J.J., Beltran B.E., Bibas M., et al. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol 2011, 86:256-261.
42. Marcucci F., Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011, 117:1792-1798.
43. Kelly G.L., Rickinson A.B. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology Am Soc Hematol Educ Program 2007, 277-284.
44. Lanoy E., Rosenberg P.S., Fily F., et al. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood 2011, 118:44-49.
45. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl 1968, 97:7.
46. Colucci S., Brunetti G., Rizzi R., et al. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. Blood 2004, 104:3722-3730.
47. Martinelli M., Martini F., Rinaldi E., et al. Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands. Am J Pathol 2002, 161:1127-1133.
48. Morelli C., Barbisan F., Iaccheri L., Tognon M. Simian virus 40 persistent infection in long-term immortalized human fibroblast cell lines. J Neurovirol 2004, 10:250-254.
49. Barbanti-Brodano G., Martini F., Corallini A., et al. Reactivation of infectious simian virus 40 from normal human tissues. J Neurovirol 2004, 10:199-205.
50. Morelli C., Barbisan F., Iaccheri L., Tognon M. SV40-immortalized human fibroblasts as a source of SV40 infectious virions. Mol Med 2004, 10:112-116.
51. Swetly P., Brodano G.B., Knowles B., Koprowski H. Response of simian virus 40-transformed cell lines and cell hybrids to superinfection with simian virus 40 and its deoxyribonucleic acid. J Virol 1969, 4:348-355.
52. Chatelut M., Caspar-Bauguil S., Tkaczuk J., et al. Establishment and characterization of a human T-lymphocyte cell line immortalized by SV40 and with abnormal expression of TCR/CD3. Scand J Immunol 1998, 48:659-666.
53. Secchiero P., Bertolaso L., Casareto L., et al. Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. Blood 1998, 92:1685-1696.
54. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
55. Pancaldi C., Corazzari V., Maniero S., et al. Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors. Blood 2011, 117:7099-7101.
56. Martini F., Lazzarin L., Iaccheri L., et al. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002, 94:1037-1048.
57. Vivaldi A., Pacini F., Martini F., et al. Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes. J Clin Endocrinol Metab 2003, 88:892-899.
58. Raetz E., Perkins S., Davenport V., Cairo M.S. B large-cell lymphoma in children and adolescents. Cancer Treat Rev 2003, 29:91-98.
59. Khot A., Dearden C. T-cell prolymphocytic leukemia. Expert Rev Anticancer Ther 2009, 9:365-371.
60. Ryan Q.C., Goonewardene I.M., Murasko D.M. Extension of lifespan of human T lymphocytes by transfection with SV40 large T antigen. Exp Cell Res 1992, 199:387-391.
61. Ryan Q.C., Goonewardene I.M., Murasko D.M. Maintenance of normal T lymphocyte function after transfection with SV40 large T. Cell Immunol 1993, 149:65-81.
62. Bocchetta M., Di Resta I., Powers A., et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000, 97:10214-10219.
63. Cacciotti P., Libener R., Betta P., et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A 2001, 98:12032-12037.
64. Bohlius J., Schmidlin K., Boue F., et al. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes. Blood 2011, 117:6100-6108.
65. Engels E.A., Cho E.R., Jee S.H. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 2010, 11:827-834.
66. Nakayama-Ichiyama S., Yokote T., Kobayashi K., et al. Primary effusion lymphoma of T-cell origin with t(7;8)(q32;q13) in an HIV-negative patient with HCV-related liver cirrhosis and hepatocellular carcinoma positive for HHV6 and HHV8. Ann Hematol 2011, 90:1229-1231.
67. Amano M., Marutsuka K., Sugimoto T., Todaka T., Setoyama M. Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia/lymphoma. J Dermatol 2011, 38:575-580.
68. Schollkopf C., Smedby K.E., Hjalgrim H., et al. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008, 122:1885-1890.
69. Banerjee P., Tripp A., Lairmore M.D., et al. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 2010, 115:2640-2648.